Drugs that are issued a Class I recall have a high probability of causing serious health consequences or death
Cuomo: "People deserve to know when a medication that's supposed to make them feel better may actually make them sicker, and it's common sense that pharmacies communicate that information to patients in real time. This measure will help ensure patients get the facts about a recalled drug quickly so they can talk to their doctor about safer alternatives."
Governor Andrew M. Cuomo today signed legislation (S.5091B/A.4781B) requiring pharmacies to inform patients of Class I drug recalls made by the FDA within three days. Drugs that are issued a Class I recall have a high probability of causing serious adverse health consequences or death. The severity of health risks associated with the use of these recalled drugs is particularly high for elderly patients and those taking long-term medications. Currently there is no requirement for pharmacies to communicate this information to patients who have received the recalled drugs.
"People deserve to know when a medication that's supposed to make them feel better may actually make them sicker, and it's common sense that pharmacies communicate that information to patients in real time," Governor Cuomo said. "This measure will help ensure patients get the facts about a recalled drug quickly so they can talk to their doctor about safer alternatives."
This law takes effect immediately. The law requires pharmacies to make a reasonable attempt to contact patients by phone or mail that have been prescribed and who are currently taking such recalled drug dispensed from such pharmacy.
Senator Leroy Comrie said, "Every year, the FDA recalls thousands of potentially harmful prescription and over the counter drugs, though countless consumers are never made aware that their medication may be putting their health in danger. This new consumer protection law will put the onus of responsibility for monitoring and informing patients of significant prescription drug recalls on the pharmacies distributing them, so timely and effective patient notification and consultation occurs at the neighborhood level. I thank Governor Cuomo and Assemblymember Daniel Rosenthal for recognizing the need for such accountability in the pharmaceutical industry."
Assembly Member Daniel Rosenthal said, "Pharmacies are often the last point of contact between a patient and their prescription. By enacting this legislation we reduce the likelihood of any New Yorker being exposed to harmful medication. I thank Senator Comrie and Governor Cuomo for their partnership in improving healthcare safety measures for countless patients and seniors."